As of 2025-08-10, the Relative Valuation of Magenta Therapeutics Inc (MGTA) is (17.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.70 USD, the upside of Magenta Therapeutics Inc based on Relative Valuation is -2596.2%.
The range of the Relative Valuation is (13.29) - (23.46) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 18.5x | 13.5x |
| Forward P/E multiples | 10.5x - 21.1x | 14.1x |
| Fair Price | (13.29) - (23.46) | (17.46) |
| Upside | -1999.3% - -3453.6% | -2596.2% |
| Date | P/E |